SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $677,018 | +2.1% | 675,000 | 0.0% | 0.64% | -13.2% |
Q4 2022 | $663,188 | +0.9% | 675,000 | 0.0% | 0.74% | -14.0% |
Q3 2022 | $657,000 | +0.2% | 675,000 | 0.0% | 0.86% | -2.7% |
Q2 2022 | $656,000 | -1.2% | 675,000 | 0.0% | 0.88% | +14.8% |
Q1 2022 | $664,000 | -0.2% | 675,000 | +99900.0% | 0.77% | +8.0% |
Q4 2021 | $665,000 | -1.0% | 675 | 0.0% | 0.71% | -32.9% |
Q3 2021 | $672,000 | +0.9% | 675 | 0.0% | 1.06% | +27.8% |
Q2 2021 | $666,000 | +2.3% | 675 | -99.9% | 0.83% | +13.2% |
Q1 2021 | $651,000 | +1.7% | 675,000 | 0.0% | 0.74% | +30.1% |
Q4 2020 | $640,000 | +29.8% | 675,000 | +25.0% | 0.56% | -18.8% |
Q3 2020 | $493,000 | – | 540,000 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|